Long-Term Effect and Safety of Tocilizumab on Severe Adult-Onset Still’s Disease Accompanied by Thrombotic Thrombocytopenic Purpura
Cite this article as: Suwabe T, Yamanouchi M, Ubara Y, Sawa N. Long-term effect and safety of tocilizumab on severe adult-onset Still’s disease accompanied by thrombotic thrombocytopenic purpura. Eur J Rheumatol. 2025, 12(4), 0029, doi: 10.5152/eurjrheum.2025.25029.
Authors
- Yoshifumi Ubara (ORCID: https://orcid.org/0000-0003-2322-8203)
- Naoki Sawa (ORCID: https://orcid.org/0000-0003-2092-4094)
- Masayuki Yamanouchi (ORCID: https://orcid.org/0000-0003-3264-9691)
- Tatsuya Suwabe (ORCID: https://orcid.org/0000-0003-0825-2512)
Institutions
- Toranomon Hospital (JP)
Publication Details
- Journal
- European Journal of Rheumatology
- Published
- 2025-12-05
- DOI
- https://doi.org/10.5152/eurjrheum.2025.0029
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00